Bayer Pharma Aktiengesellschaft

Bayer Animal Health Gmbh

Maria De Lourdes Mottier

Gerald Beddies

Ulf Bömer

Nils Griebenow

Ulrich Bothe

Iring Heisler

Reinhard Nubbemeyer

Nicole Schmidt

Jörg Cramer

Ulf Boemer

Adrian Foster

The present application relates to the use of substituted indazoles for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially for treatment and/or prophylaxis of atopic dermatitis, Flea Allergy Dermatitis, inflammatory bowel disease, osteoarthritis and inflammatory pain, non-infectious recurrent airway disease, insect hypersensitivity, asthma, respiratory disease, mastitis and endometritis in animals.

Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals

The present application relates to the use of fused heteroaromatic pyrrolidones for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals and to the use thereof for production of medicaments for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially of atopic dermatitis and/or Flea Allergy Dermatitis, and especially in domestic animals, particularly in dogs.

Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals

Growing community of inventors

Langenfeld, Germany

Maria De Lourdes Mottier